FindTrial
Sign In

Skin changes in Type 2 Diabetes Mellitus and its correlation with Glycosylated Hemoglobin

Pattern of Mucocutaneous Manifestations in Type 2 Diabetes Mellitus and its correlation with Glycosylated Hemoglobin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034134
Enrollment
88
Registered
2021-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

DR VENKATARAMAN SATEESH JOSHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL PATIENTS DIAGNOSED TO HAVE TYPE 2 DM INCLUDING NEWLY DETECTED, FULLFILLING AMERICAN DIABETIC ASSOCIATION (ADA) CRITERIA WITH MUCOCUTANEOUS MANIFESTATIONS.

Exclusion criteria

Exclusion criteria: 1)PATIENTS OF TYPE 1 DIABETES 2)PATIENTS WITH KNOWN COMORBID CONDITIONS REQUIRING LONG TERM CORTICOSTEROIDS 3)PATIENTS WHO ARE IMMUNOCOMPROMISED 4)PATIENTS WITH THYROID DISORDERS 5)PATIENTS WITH GESTATIONAL DIABETES MELLITUS 6)PATIENTS WITH SEXUALLY TRANSMITTED DISEASE

Design outcomes

Primary

MeasureTime frame
1)TO CORRELATE GLYCOSYLATED HEMOGLOBIN LEVELS WITH VARIOUS MUCOCUTANEOUS MANIFESTATIONS IN TYPE 2 DIABETESTimepoint: IMMEDIATE—

Secondary

MeasureTime frame
2)TO STUDY THE CLINICAL PATTERN OF MUCOCUTANEOUS MANIFESTATIONS IN TYPE 2 DIABETESTimepoint: IMMEDIATE—

Countries

India

Contacts

Public ContactDR ROSHAN M

FATHER MULLER MEDICAL COLLEGE

mroshan@rediffmail.com9845138717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026